VA797P-16-R-0038 Terazosin Capsules

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) VA797P-16-R-0038 for an unrestrictive procurement for Terazosin HCL Capsules for the Department of Veterans Affairs (VA), Department of Defense (DOD), Indian Health Service (IHS) and Bureau of Prisons (BOP).The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA's and DOD's respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. All tablets/bottles must be compatible with automated dispensing units (Baxter ATC Canisters, Optifil, etc.). All bottles of 100 tablets/capsules or less must have a child resistant closure. If the offeror is not a manufacturer, a signed agreement between the offeror and the manufacturer must be submitted with the offer and remain in effect for the duration of the contract period including the option years. Solicitation No VA797P-16-R-0038 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 22, 2016, with a tentative closing date of March 15, 2016. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Bonita Smith. Questions can be e-mailed to: Bonita.Smith@va.gov



The estimated annual usage is as follows:













ITEM







DESCRIPTION



PACKAGE SIZE (BOTTLES) TOTAL ESTIMATED ANNUAL USAGE (BOTTLES)

1 TERAZOSIN HCL 10MG CAP 100

6,757

2a TERAZOSIN HCL 10MG CAP 500

50,078



OR OR OR OR

2b

TERAZOSIN HCL 10MG CAP 1000

25,039



3

TERAZOSIN HCL 1MG CAP 100

4,359



4a TERAZOSIN HCL 1MG CAP 500 20,458

OR OR OR OR

4b TERAZOSIN HCL 1MG CAP 1000 10,229

5 TERAZOSIN HCL 2MG CAP 100 15,916

6a TERAZOSIN HCL 2MG CAP 500 100,128

OR OR OR OR

6b TERAZOSIN HCL 2MG CAP 1000 50,064

7 TERAZOSIN HCL 5MG CAP 100 10,079

8a TERAZOSIN HCL 5MG CAP 500 64,692

OR OR OR OR

8b TERAZOSIN HCL 5MG CAP 1000 32,346





Total Estimate (total includes only ONE item where an item has an option of a or b)